Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1958 1
1968 1
1970 1
1974 2
1980 2
1981 2
1982 2
1983 2
1984 1
1986 2
1987 2
1988 5
1989 1
1990 4
1991 3
1992 12
1993 9
1994 14
1995 6
1996 8
1997 4
1998 10
1999 4
2000 8
2001 9
2002 9
2003 6
2004 10
2005 7
2006 9
2007 5
2008 12
2009 3
2010 6
2011 7
2012 7
2013 7
2014 11
2015 9
2016 6
2017 7
2018 5
2019 9
2020 11
2021 9
2022 5
2023 4
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

260 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O'Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR; KEYNOTE-024 Investigators. Reck M, et al. N Engl J Med. 2016 Nov 10;375(19):1823-1833. doi: 10.1056/NEJMoa1606774. Epub 2016 Oct 8. N Engl J Med. 2016. PMID: 27718847 Free article. Clinical Trial.
Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report.
Knaul FM, Farmer PE, Krakauer EL, De Lima L, Bhadelia A, Jiang Kwete X, Arreola-Ornelas H, Gómez-Dantés O, Rodriguez NM, Alleyne GAO, Connor SR, Hunter DJ, Lohman D, Radbruch L, Del Rocío Sáenz Madrigal M, Atun R, Foley KM, Frenk J, Jamison DT, Rajagopal MR; Lancet Commission on Palliative Care and Pain Relief Study Group. Knaul FM, et al. Lancet. 2018 Apr 7;391(10128):1391-1454. doi: 10.1016/S0140-6736(17)32513-8. Epub 2017 Oct 12. Lancet. 2018. PMID: 29032993 Review. No abstract available.
Cardiovascular Pharmacology.
Mason JM, O'Brien ME, Koehl JL, Ji CS, Hayes BD. Mason JM, et al. Among authors: o brien me. Emerg Med Clin North Am. 2022 Nov;40(4):771-792. doi: 10.1016/j.emc.2022.06.012. Epub 2022 Oct 7. Emerg Med Clin North Am. 2022. PMID: 36396221 Review.
Metoprolol for the Prevention of Acute Exacerbations of COPD.
Dransfield MT, Voelker H, Bhatt SP, Brenner K, Casaburi R, Come CE, Cooper JAD, Criner GJ, Curtis JL, Han MK, Hatipoğlu U, Helgeson ES, Jain VV, Kalhan R, Kaminsky D, Kaner R, Kunisaki KM, Lambert AA, Lammi MR, Lindberg S, Make BJ, Martinez FJ, McEvoy C, Panos RJ, Reed RM, Scanlon PD, Sciurba FC, Smith A, Sriram PS, Stringer WW, Weingarten JA, Wells JM, Westfall E, Lazarus SC, Connett JE; BLOCK COPD Trial Group. Dransfield MT, et al. N Engl J Med. 2019 Dec 12;381(24):2304-2314. doi: 10.1056/NEJMoa1908142. Epub 2019 Oct 20. N Engl J Med. 2019. PMID: 31633896 Free PMC article. Clinical Trial.
Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer.
von Pawel J, Jotte R, Spigel DR, O'Brien ME, Socinski MA, Mezger J, Steins M, Bosquée L, Bubis J, Nackaerts K, Trigo JM, Clingan P, Schütte W, Lorigan P, Reck M, Domine M, Shepherd FA, Li S, Renschler MF. von Pawel J, et al. Among authors: o brien me. J Clin Oncol. 2014 Dec 10;32(35):4012-9. doi: 10.1200/JCO.2013.54.5392. Epub 2014 Nov 10. J Clin Oncol. 2014. PMID: 25385727 Clinical Trial.
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.
O'Brien ME, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A, Catane R, Kieback DG, Tomczak P, Ackland SP, Orlandi F, Mellars L, Alland L, Tendler C; CAELYX Breast Cancer Study Group. O'Brien ME, et al. Ann Oncol. 2004 Mar;15(3):440-9. doi: 10.1093/annonc/mdh097. Ann Oncol. 2004. PMID: 14998846 Free article. Clinical Trial.
Relief of suffering.
O'Brien ME. O'Brien ME. Postgrad Med. 1996 Jun;99(6):189-208. doi: 10.1080/00325481.1996.11946144. Postgrad Med. 1996. PMID: 29206586
Risk of Serotonin Syndrome with Isoniazid.
O'Brien ME, Gandhi RG, Kotton CN, Adamsick ML. O'Brien ME, et al. Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01455-20. doi: 10.1128/AAC.01455-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33077663 Free PMC article. No abstract available.
Targeting the PD-1/PD-L1 axis in non-small cell lung cancer.
Kumar R, Collins D, Dolly S, McDonald F, O'Brien MER, Yap TA. Kumar R, et al. Among authors: o brien mer. Curr Probl Cancer. 2017 Mar-Apr;41(2):111-124. doi: 10.1016/j.currproblcancer.2016.12.002. Epub 2016 Dec 23. Curr Probl Cancer. 2017. PMID: 28214087 Review.
260 results